Mid
P
PFEAI Stock Diagnostic Report
Pfizer reports phase 2 data for 25-valent pneumococcal vaccine
Fidelity reported Phase 2 data for the pneumococcal vaccine, but as the direction of the results is not specified, the stock price impact is neutral.
View Source Article ↗
AI CATALYST SCORE55 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
PFE Analysis History (Last 30 Days)